Your shopping cart is currently empty

SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $31 | In Stock | In Stock | |
| 2 mg | $44 | In Stock | In Stock | |
| 5 mg | $72 | In Stock | In Stock | |
| 10 mg | $101 | In Stock | In Stock | |
| 25 mg | $177 | In Stock | In Stock | |
| 50 mg | $237 | In Stock | In Stock | |
| 100 mg | $431 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $55 | In Stock | In Stock |

| Description | SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models. |
| Targets&IC50 | SHP2:0.07 μM, pERK:0.250 μM, BXPC-3 cells:72.86 μM, SHP2 (E69K):0.416 μM, TF-1 cell:1.73 μM, 4T1 cells:119.3 μM, SHP2E76K:2.896 μM, ASPC1 cells:64.04 μM, SHP2 (D61Y):1.241 μM, BaF3 cells:19.86 μM, Capan-2 cells:15.67 μM, SHP2A72V:1.968 μM, MV-4-11 cells:0.32 μM |
| Synonyms | SHP099 free base, SHP-099, SHP 099 |
| Molecular Weight | 352.26 |
| Formula | C16H19Cl2N5 |
| Cas No. | 1801747-42-1 |
| Smiles | CC1(N)CCN(CC1)c1cnc(c(N)n1)-c1cccc(Cl)c1Cl |
| Relative Density. | 1.326 g/cm3 (Predicted) |
| Storage | store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 15.8 mg/mL (44.85 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.84 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.